Back to today’s briefing

Story perspectives

E. coli: The Biotech Powerhouse Transforming Pharmaceuticals

9/28/2025

46 3

Summary

Story summary

E. coli is a key bacterium in biotechnology, enabling production of pharmaceuticals like insulin and paracetamol.
E. coli was first isolated in 1885 and became a model organism for fast growth and easy manipulation.
Its role expanded after the 1940s, showing gene sharing that advanced genetics.
Cynthia Collins of Ginkgo Bioworks notes E. coli's robustness and cost-effectiveness in industry.

1 of 1

Story summary

E. coli is a key bacterium in biotechnology, enabling production of pharmaceuticals like insulin and paracetamol.
E. coli was first isolated in 1885 and became a model organism for fast growth and easy manipulation.
Its role expanded after the 1940s, showing gene sharing that advanced genetics.
Cynthia Collins of Ginkgo Bioworks notes E. coli's robustness and cost-effectiveness in industry.